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ABSTRACT
Background: Despite numerous animal studies that have illustrated
the impact of additional vitamin D in the diet of hens on the result-
ing egg vitamin D content, the effect of the consumption of such
eggs on vitamin D status of healthy individuals has not, to our
knowledge, been tested.
Objective: We performed a randomized controlled trial (RCT) to in-
vestigate the effect of the consumption of vitamin D–enhanced eggs
(produced by feeding hens at the maximum concentration of vitamin
D3 or serum 25-hydroxyvitamin D [25(OH)D3] lawfully allowed in
feed) on winter serum 25(OH)D in healthy adults.
Design: We conducted an 8-wk winter RCT in adults aged 45–70 y
(n = 55) who were stratified into 3 groups and were requested to
consume #2 eggs/wk (control group, in which status was expected
to decline), 7 vitamin D3–enhanced eggs/wk, or seven 25(OH)D3-
enhanced eggs/wk. Serum 25(OH)D was the primary outcome.
Results: Although there was no significant difference (P . 0.1;
ANOVA) in the mean preintervention serum 25(OH)D in the 3
groups, it was w7–8 nmol/L lower in the control group than in
the 2 groups who consumed vitamin D–enhanced eggs. With the
use of an ANCOVA, in which baseline 25(OH)D was accounted for,
vitamin D3–egg and 25(OH)D3-egg groups were shown to have had
significantly higher (P # 0.005) postintervention serum 25(OH)D
than in the control group. With the use of a within-group analysis, it
was shown that, although serum 25(OH)D in the control group
significantly decreased over winter (mean 6 SD: 26.4 6 6.7 nmol/L;
P = 0.001), there was no change in the 2 groups who consumed vitamin
D–enhanced eggs (P . 0.1 for both).
Conclusion: Weekly consumption of 7 vitamin D–enhanced eggs
has an important impact on winter vitamin D status in adults. This
trial was registered at clinicaltrials.gov as NCT02678364. Am J
Clin Nutr 2016;104:629–37.
Keywords: bioaddition, RCT, vitamin D deficiency, vitamin D–
enhanced eggs, 25(OH)D
INTRODUCTION
Data from the United States and Europe have suggested that
8% and 13% of the population, respectively (1, 2), have serum 25-
hydroxyvitamin D [25(OH)D]8 concentrations ,30 nmol/L,
which are reflective of vitamin D deficiency (3). Current dietary
intakes of most populations, young and adult, on either side of
the Atlantic are well short of dietary reference values for vitamin
D (3–6), thereby contributing to the risk of vitamin D deficiency.
The fortification of food with vitamin D has been suggested as
a strategy with the potentially widest reach and impact in the
population in terms of enhancing vitamin D intakes and mini-
mizing the risk of vitamin D deficiency (6–9).
Although traditional fortification practices in which exogenous
vitamin D is added to foods will continue to be an important
approach for increasing the content of vitamin D (8), the use of
the bioaddition approach to enhance the vitamin D content of
foods (9) also merits serious attention not only because it may
hold more consumer appeal in some cases but also because it may
increase other metabolites of vitamin D that would boost the
overall relative effectiveness of these foods in raising vitamin D
status (7). For example, there have been several reports that have
shown that the vitamin D3 content of eggs can be substantially
increased by the greater addition of vitamin D3 to the feed of
hens (10–16), albeit several of the studies (11, 12, 14, 15) used
amounts for inclusion above the upper allowable amount for
feeds in Europe [3000 IU/kg diet (17)]. The addition of com-
mercially available 25(OH)D3 to the diet of hens has also been
shown to increase the 25(OH)D3 content of eggs (13, 15, 16),
albeit 2 studies used 25(OH)D3 at amounts above the upper
allowable amount [0.080 mg/kg diet (18)]. The use of a con-
version factor of 5 [on the basis that supplemental 25(OH)D3
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was 5 times more potent in raising the winter serum 25(OH)D of
older men and women than was an equivalent amount of sup-
plemental vitamin D3 (19)] from our randomized controlled trial
(RCT) to calculate the total vitamin D activity of vitamin D–
enhanced eggs, showed that eggs from hens fed 25(OH)D3
(3000 IU/kg diet) or an equivalent amount of vitamin D3 had
a total vitamin D activity of 5.1 and 3.8 mg/egg, respectively
(16). However, this result assumes that the bioavailability of
25(OH)D3 from supplements and food matrices is similar. In
addition, other authors have reported lower conversion factors
that ranged from 1 to 3 (20, 21), which would translate into eggs
with an overall 0.7–3.6-mg lower total vitamin D activity be-
cause of the reduced impact of the 25(OH)D3 content. More-
over, despite numerous studies on the impact of additional
vitamin D in the diet of hens on the resulting egg vitamin D
content (10–16), the effect of the consumption of such vitamin
D–enhanced eggs on vitamin D status of healthy human subjects
has not been tested in an RCT to our knowledge. A cross-sectional
study of 564 school children (aged 9–12 y) in Spain showed that
those who consumed ,0.5 usual eggs/d had significantly lower
serum 25(OH)D (byw10 nmol/L) than children who consumed
$0.5 eggs/d (22).
To date, studies on the sensory acceptability of vitamin D3–
enhanced eggs have been on eggs in which the hens received
well above the European allowable upper amount (11, 14), and
to our knowledge, 25(OH)D3-enhanced eggs have not been
tested. Therefore, the primary objective of the current work was
to investigate the effect of the consumption of vitamin D3– or
25(OH)D3-enhanced eggs on winter serum 25(OH)D in adults in
a 8-wk RCT. The secondary objective was to undertake a sen-
sory evaluation of vitamin D–enhanced eggs to ascertain their
consumer acceptability.
METHODS
Sensory analysis of vitamin D–enhanced eggs
Eggs from our previous hen feeding trial, whereby hens were
fed one of 4 dietary treatments in which the vitamin D content or
form differed (i.e., treatment 1: 1500 IU vitamin D3/kg diet [this
amount is one-half the upper allowable amount in Europe (17)
and may be more reflective of that used in some commercial
production, as evidenced by the wide variability in the vitamin D
content of commercial eggs in Europe (13) as well as in the
United States (23)]; treatment 2: 3000 IU vitamin D3/kg diet;
treatment 3, 1500 IU vitamin D3 plus 1500 IU (37.5 mg) 25(OH)D3
(HyD; DSM Nutritional Products Ltd.)/kg diet; and treatment
4: 3000 IU (75 mg) 25(OH)D3/kg diet (16)), with the initial aim
of identifying the dietary treatment that yielded eggs with the
highest total vitamin D activity, were used for this associated
sensory analysis. The total vitamin D activity [with the use of
data derived from the National Food Institute, Technical Uni-
versity of Denmark, where the vitamin D3 and 25(OH)D3 con-
tents of pooled egg-yolk samples for each treatment were
measured with the use of liquid chromatography–tandem mass
spectrometry (LC-MS/MS) (24) (pools were derived from n =
12–15 egg yolks/treatment)] was calculated as follows: vitamin
D3 + [25(OH)D3 3 5]. The conversion factor of 5 that was
applied to the 25(OH)D3 content was based on data from our
previous RCT (19), as mentioned previously, and this factor is
commonly used in several food-composition tables, including
those in the United Kingdom (25–27). The mean 6 SD total
vitamin D activity in the pooled egg-yolk samples was 2.8 6
0.5, 3.8 6 0.3, 4.8 6 0.8, and 5.1 6 0.5 mg/egg for treatments
1–4, respectively (16). Eggs (both boiled and fried) were pre-
pared and cooked as follows. In the case of boiled eggs, whole
eggs were placed in a saucepan of cold water and boiled for
10 min on a conventional cooker hob. After cooking, eggs were
cooled in cold water, the shells were removed, and each boiled
egg was cut in half (longitudinally) before presentation to sen-
sory panelists. In the case of fried eggs, eggs were cracked open
and cooked (5 min in vegetable oil) within stainless-steel
cooking rings placed in a frying pan to ensure the uniformity and
consistency of fried eggs for sensory evaluation. Fried eggs were
cut in half and reheated for 20 s in a microwave before pre-
sentation to sensory panelists.
A sensory evaluation of boiled and fried eggs was carried out in
2 separate sensory analysis sessions with the use of 22 and 18
consented, naive assessors, respectively, whereby 4 egg samples
(one sample from each of treatments 1–4), which were identified
with random 3-digit codes, were presented to each panelist in
duplicate. The sample presentation order was randomized to
prevent any flavor-carryover effects. The sensory analysis was
undertaken in panel booths at a sensory laboratory in the School
of Food and Nutritional Sciences, University College Cork, in
accordance with International standards (28). Assessors were
also provided with water and crackers to cleanse their pallets
between samples.
Hedonic [appearance, liking of flavor, liking of texture, and
overall acceptability (dislike or like; unacceptable or acceptable)]
and intensity sensory-analysis descriptors [yolk color (yellow or
orange), egg white (white or gray), sulfur flavor (none or ex-
treme), sour (not or very), sweet (not or very), salty (not or very),
odor (weak or strong), and off flavor (none or extreme)] were
determined whereby assessors were asked to indicate their degree
of liking on a 10-cm continuous line scale that ranged from zero
to 10. Results for sensory analysis scores were measured in cm.
Subjects for RCT
A total of 55 apparently healthy, free-living adults, aged 45–
70 y, were recruited into this 8-wk food-based vitamin D in-
tervention trial. Subjects were recruited in the Cork area through
the use of advertisements that were placed around University
College Cork and across the location. We aimed to recruit ap-
proximately equal numbers of men and women. Inclusion cri-
teria were consenting white men and women aged 45–70 y.
Volunteers were excluded if they were unwilling to discontinue
the consumption of vitamin D–containing supplements for 4 wk
before the initiation of the study and throughout the study.
Volunteers were also excluded if they planned to take a winter
vacation (during the course of the 8-wk intervention) to a loca-
tion where either the altitude or the latitude would be predicted
to result in significant cutaneous vitamin D synthesis from solar
radiation (e.g., a winter-sun coastal resort or a mountain ski
resort) or if they used tanning facilities of any type. Additional
reasons for exclusion were a severe medical illness, an allergy
to egg products, being medically advised to limit egg intake
in relation to managing hypercholesterolemia, hypercalcemia,
known intestinal malabsorption syndrome, excessive alcohol use,
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and the use of medications known to interfere with vitamin D
metabolism. The study was approved by the Clinical Research
Ethics Committee of the Cork Teaching Hospitals, University
College Cork. All participants gave their written informed consent
according to the Helsinki Declaration. This trial was registered at
clinicaltrials.gov as NCT02678364.
Rationale and design of RCT
The study was a controlled, food-based intervention trial in
which adults (aged 45–70 y) were randomly assigned to 3
groups. A control group, who habitually consumed only #2
eggs/wk and who agreed to do so for the duration of the RCT,
and 2 vitamin D groups, who were habitual egg consumers and
were willing to consume 7 eggs/wk, received either 7 vitamin
D3–enhanced eggs (vitamin D3–egg group) or seven 25(OH)D3-
enhanced eggs [25(OH)D3-egg group) a week for 8 wk. The
rationale for the inclusion of a control group was to show that
serum 25(OH)D concentrations decreased over the 8 wk of the
winter RCT akin to a placebo group in our previous vitamin D
RCTs (19, 29, 30). Our initial hen-feed trial showed that even
the use of only one-half of the upper allowable amount of vi-
tamin D in feeds led to eggs with a considerable total vitamin D
activity (2.8 mg/egg) (16); thus, it was not feasible to supply
7 eggs/wk without having an impact on the vitamin D status of
the control group. Therefore, we chose to limit the egg con-
sumption to a maximum of 2 eggs/wk (participants were not
required to consume these 2 eggs, but if they consumed eggs,
they were asked to limit their consumption to 2 eggs/wk), and in
terms of feasibility, we selected habitual low consumers of eggs
for this control group to enhance compliance over the 8 wk. We
felt that this was a more feasible approach than requesting
participants who were habitual egg consumers and stratified to
the control group to limit their egg intake to #2 eggs/wk over
8 wk, which could have been challenging. The 2 vitamin D groups
were egg consumers who were willing to consume 7 eggs/wk.
Seven and 1–2 eggs/wk (including eggs in dishes) were consistent
with the amounts that are consumed in the highest and lowest
tertiles, respectively, of adult egg consumers in Ireland on the basis
of data from the National Adult Nutrition Survey (31). From
a dietary guideline perspective, the general population can include
#7 eggs/wk in their diets (32). The random assignment of subjects
in the 2 vitamin D–enhanced–egg groups was centralized, com-
puter generated, and accounted for sex.
Vitamin D intake from food sources in the control group was
expected to be close to that in the general adult population aged
50–70 y (w5 mg/d) (5), whereas intakes in the 2 vitamin D–
enhanced–egg groups were expected to be w10 mg/d on the
basis of the additional vitamin D activity provided by the eggs.
However, the w10 mg/d in the 25(OH)D3-egg group was
based on the assumption that the 25(OH)D in the eggs would
behave in a similar manner to the synthetic 25(OH)D that was
used by us in our previous RCT of older adults, which was
shown to increase serum 25(OH)D more effectively (consump-
tion of 1 mg/d was equivalent to consumption of 5 mg vitamin
D3/d) (19), and for which some food-composition tables have
assumed a factor of 5 (25–27). However, as mentioned pre-
viously, it may be that the bioavailability of 25(OH)D means
that, at worst, it will only be equivalent to vitamin D3 as has
been suggested by some researchers (20). Thus, intakes of
vitamin D may have been only 6.5 mg/d in the 25(OH)D3-egg
group.
Eggs for RCT
Both forms of vitamin D were approved by the European
Commission expert group (Panel on Additives and Products or
Substances used in Animal Feed) for inclusion in animal feed-
stuffs (17, 18), and the vitamin D3– and 25(OH)D3-enhanced
eggs for the RCTwere supplied on a weekly basis by the School
of Agricultural and Food Science, University College Dublin.
The experimental vitamin D3– and 25(OH)D3-containing hen
diets, each of which were produced at the beginning of the
feeding trial in 100-kg batches, were based on a basic diet that
contained crude protein (155 g/kg) and metabolizable energy
(10.44 MJ/kg). The diets were also balanced for amino acid
profiles and fatty acid contents and were provided in a layer
mash form. Information on the composition of the hen diet used
in the production of commercially available eggs was not known
to us.
The eggs were placed in specifically purchased cardboard egg
boxes labeled with the use-by date and subject IDs by staff who
were not involved in the conduct of the RCT. The control (non–
vitamin D–enhanced) eggs were purchased locally at a major
retail store and were provided to all subjects in the control group
for consistency. The vitamin D3 and 25(OH)D3 contents of the 3
types of eggs used in this trial [i.e., commercially available
(control) eggs, vitamin D3–enhanced eggs, and 25(OH)D3-enhanced
eggs) were assessed with the use of an in-house HPLC analysis
within the Cork Centre for Vitamin D and Nutrition Research
(CCVDNR), University College Cork.
Conduct of RCT
The study was carried out in Cork, Ireland (latitude: 518N). All
subjects were screened, recruited, and commenced the inter-
vention study between 5 and 30 January 2015 and finished the
study 8 wk later between 3 and 30 March 2015, during which
the vitamin D status was expected to decline to a nadir (33).
During the intervention phase, each participant was met by re-
searchers on 2 sampling occasions at the human dietary studies
unit at the CCVDNR at the baseline (week 0) and endpoint
(week 8) of the study. At each visit, an overnight fasting blood
sample was taken from each participant between 0830 and 1030
by a trained phlebotomist. Blood was collected by venipuncture
into an evacuated tube with no additive and processed to serum,
which was immediately stored at 2808C until required for anal-
ysis. Anthropometric measures, including height and weight, were
taken as described previously (34). Habitual intake of vitamin
D (and calcium) was estimated via a validated food-frequency
questionnaire (FFQ) (35, 36) that was administered by a research
nutritionist at the baseline. The FFQ, which had been tailored with
the use of national food-consumption survey data obtained from
Irish adults (aged 18–64 y) so as to identify foods that contribute
95% of vitamin D intake, has been shown to have a generally
good level of agreement with a 14-d diet-history method and
without a significant overall bias or proportional bias (36).Note
that the FFQ was not designed to measure energy or other nu-
trient intakes and was designed to be administered by a trained
researcher in association with validated methods of estimating
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portion sizes (36). In addition, a health and lifestyle question-
naire, which assessed physical activity, general health, smoking
status, and alcohol consumption, was completed at the baseline.
Participants either collected their weekly and fortnightly allo-
cation of fresh eggs at the human dietary studies unit, or in some
cases when this was not feasible, the eggs were delivered to
them. This regular contact also served to promote compliance
and encourage the completion of the study protocol. The par-
ticipants were asked to use the study-provided eggs in place of
their normally purchased eggs for the duration of the study
period. Subjects were requested to use the whole egg because
egg white has a low vitamin D content (37). Subjects were
provided with cooking suggestions and meal ideas for the in-
corporation of the vitamin D–enhanced whole eggs into their
weekly diet. Compliance was assessed with the use of an egg
diary. Although the control group were aware of their allocation
by virtue of being limited to 2 eggs/wk, the allocation of the 2
vitamin D–enhanced–egg groups remained concealed from both
participants and staff involved in the conduct of the RCT until
the final analyses was complete. Biochemical outcome measures
were reported by people who were masked to the allocation
schemes of all subjects.
Laboratory analysis
HPLC analysis of RCT eggs
The separated yolks from 6 individual eggs/treatment were
analyzed for vitamin D3 and 25(OH)D with the use of an in-
house HPLC method at the CCVDNR. The extraction procedure
was adapted from Jakobsen et al. (38), and after semipreparative
steps that have been described elsewhere (38, 39), vitamin D3
and 25(OH)D were quantified with the use of an HPLC system
(Shimadzu Corp.) consisting of 2 LC20ADXR pumps, an SIL-
30AC autosampler, a CTO-20AC column oven, an SPD-30MA
PDA detector, a FRC-10A fraction collector, and a CBM-20A
system controller. Concentrations of vitamin D3 and 25(OH)D3
were calculated on the basis of an external calibration and ad-
justed for the percentage of recovery of the internal standard. In
addition, because the eggs from our original hen-feeding trial
were analyzed with the use of an LC-MS/MS method at the
National Food Institute, Technical University of Denmark (24),
the data were aligned with that method to ensure comparability.
The National Food Institute laboratory has been accredited for
vitamin D and 25(OH)D since 1994 and 2004, respectively. For
the last 15 y, the laboratory has performed the analysis for vi-
tamin D and 25(OH)D in food for the Danish and Norwegian
food-composition tables.
Serum 25(OH)D
Concentrations of total 25(OH)D [i.e., 25(OH)D2 plus 25(OH)D3]
in all serum samples were measured at the CCVDNR with
the use of an LC-MS/MS method that has been described in
detail elsewhere (40). The intra-assay CV of the method was
,5% for all 25(OH)D metabolites, whereas the interassay CV
was ,6%. The CCVDNR is a participant in the Vitamin D
Standardization Program (41) and is certified by the CDC’s
Vitamin D Standardization Certification Program (42). In addi-
tion, the quality and accuracy of the serum 25(OH)D analysis
conducted with the use of LC-MS/MS in our laboratory is
monitored on an ongoing basis by participation in the Vitamin D
External Quality Assessment Scheme (Charing Cross Hospital).
Serum intact parathyroid hormone
Serum parathyroid hormone (PTH) concentrations were mea-
sured at the CCVDNR in all serum samples with the use of an
ELISA (intact PTH; MD Biosciences Inc.) Intra-assay and inter-
assay CVs were 3.4% and 3.8%, respectively.
Serum total calcium and cholesterol
Total calcium, albumin, and cholesterol concentrations were
measured at the CCVDNR in all serum samples with the use of
a fully automated clinical analyzer (RX Monacol Randox Labo-
ratories Ltd. Co.). Interassay CVs were 2.2%, 1.9%, and 2.2% for
total calcium, albumin, and cholesterol, respectively. Serum cal-
cium concentrations were adjusted for albumin concentrations.
Sample-size estimation
We wanted to be able to compare the endpoint (March) serum
25(OH)D concentration between the control group and the serum
25(OH)D concentrations in both of the vitamin D–enhanced–egg
groups, which were predicted to havew5 mg additional vitamin
D/d. Our previous vitamin D RCTs in young and older adults
(29, 30) have shown that there was a 12-nmol/L higher mean
endpoint serum 25(OH)D concentration in the 5-mg vitamin D/d
treatment groups than in the respective placebo groups. On the
basis of the distribution of serum 25(OH)D data from our pre-
vious study of older adults, which was conducted at the same
time of year (19), our power estimates, which were based on
a 12-nmol/L difference in serum 25(OH)D between the control
group and either of the vitamin D–enhanced–egg groups in-
dicated a need for 17 volunteers/group (n = 51 in total) for 90%
assurance at a = 0.5. We did not power the study to detect
differences between the 2 vitamin D–enhanced–egg groups be-
cause this was not the primary objective.
Statistical analysis
A statistical analysis of the sensory score data, which was
conducted with the use of an ANOVA partial least-squares re-
gression, was performed with Unscrambler software (version
10.3; CAMO ASA). The statistical analysis of the RCT data was
conducted with the use of SPSS for Windows software (version
20.0; SPSS Inc.). Distributions of all variables were tested with
the use of Kolmogorov-Smirnov tests. Descriptive statistics
(means 6 SDs or medians and IQRs when appropriate) were
determined for all variables. A 1-factor ANOVA was used to
compare the mean total vitamin D activity of 3 types of RCT
eggs. Dietary calcium and serum PTH were not normally dis-
tributed and, thus, were log transformed to achieve near-normal
distributions. Serum concentrations of 25(OH)D, albumin-
corrected calcium, and total cholesterol as well as age, weight,
height, BMI, and dietary vitamin D were normally distributed.
Baseline characteristics of male and female subjects were
compared with the use of unpaired Student’s t tests. Baseline
characteristics of subjects in the different intervention groups
were compared with the use of a chi-square test (for the ratio of
men to women) and a 1-factor ANOVA. An ANCOVA (with
adjustment for the baseline variable being tested) was used to
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test between intervention-group effects of treatment on weight
as well as serum 25(OH)D, PTH, albumin-corrected calcium,
and total cholesterol concentrations, and the Tukey’s test was
used for the post hoc analysis. Linear models of the response in
a repeated-measures analysis for the differences in weight as
well as of serum 25(OH)D, PTH, albumin-corrected calcium,
and total cholesterol concentrations were also constructed. Main
effects included dietary treatment and sex. Linear models also
included 2-way interactions between main effects. Paired t tests
were used to test changes within intervention groups from prein-
tervention to postintervention concentrations of serum 25(OH)D,
PTH, albumin-corrected calcium, and total cholesterol concen-
trations. Subjects included in the analyses and those who were not
included (i.e., dropouts) were compared on the basis of selected
characteristics with the use of 2-sample t tests (continuous vari-
ables) and chi-square tests (categorical variables). P , 0.05 was
considered significant.
An intention-to-treat analysis of the serum 25(OH)D data as
the primary outcome measure was also performed to account for
the 4 subjects who dropped out. The 4 missing postintervention
values for serum 25(OH)D were imputed with the use of the
multiple-imputation function in the SPSS program (k = 5) as
suggested by Armijo-Olivo et al. (43). This analysis was viewed
as confirmatory of that in which the 4 dropouts were excluded.
RESULTS
Sensory evaluation of vitamin D–enhanced eggs
An ANOVA partial least-squares regression analysis of the
sensory evaluation data on vitamin D–enhanced eggs from our
initial hen trial (16) showed that there were no significant (P .
0.05) differences in hedonic or intensity sensory scores between
vitamin D3 and 25(OH)D3 eggs (treatments 2 and 4, respec-
tively) whether as boiled eggs (Supplemental Table 1) or as
fried eggs (Supplemental Table 2). The consumer acceptability
of eggs from hens that were fed treatments 2 and 4 did not differ
from each other or from the other 2 treatments (i.e., treatments
1 and 3) (Supplemental Tables 1 and 2).
Vitamin D activity of eggs for RCT
The HPLC analysis of the 3 types of eggs used in the current
RCT (n = 6 eggs/group) showed that the means 6 SDs of vi-
tamin D3, 25(OH)D3, and total vitamin D activity (i.e., vitamin
D3 + [25(OH)D3 3 5]) for vitamin D3 eggs were 1.04 6 0.54,
0.50 6 0.10, and 3.54 6 1.04 mg/egg, respectively. The means 6
SDs of vitamin D3, 25(OH)D3, and total vitamin D activity for
25(OH)D3 eggs were 0.14 6 0.08, 0.88 6 0.26, and 4.54 6
1.38 mg/egg, respectively. The means 6 SDs of vitamin D3;
25(OH)D3; and total vitamin D activity for the commercially
available (control) eggs were 0.63 6 0.22, 0.56 6 0.22, and
3.43 6 1.31 mg/egg, respectively. There was no significant
difference in the mean total vitamin D activity across the 3
types of eggs (P = 0.13; ANOVA).
Baseline characteristics of subjects in the RCT
Of 55 subjects who were recruited onto the study, 51 subjects
completed the intervention. The progress of these subjects
through the trial is shown in Figure 1. Baseline characteristics of
subjects who entered the intervention are shown in Table 1.
Although women were, on average, lighter and smaller than men
(both P , 0.0001) and had lower BMI (P , 0.05) and habitual
intake of calcium (P , 0.05), there was no difference (P . 0.2
for all) in the mean age, habitual intakes of vitamin D, serum
25(OH)D, PTH, albumin-corrected calcium, or cholesterol con-
centrations between men and women at baseline (data not
shown).
Effects of intervention with vitamin D–enhanced eggs
There was no difference (P . 0.3) in the mean age, weight,
height, or BMI at baseline in the 3 treatment groups [control, vi-
tamin D3–egg, and 25(OH)D3-egg groups] (data not shown).
Similarly, there was no significant difference (P . 0.9) in the
proportion of men to women in treatment groups (Table 1).
Habitual dietary vitamin D and calcium intakes are shown in Table
1, and these intakes were similar in the 3 treatment groups (P. 0.1).
There were no adverse events reported during the study. Of 4
dropouts, one subject was from the control group, one subject was
from the vitamin D3–egg group, and 2 subjects were from the
25(OH)D3-egg group. A dropout during the intervention phase
was for reasons of a loss of interest or a back injury, and in no
instance was a dropout related to the intervention. The 51
subjects who completed the study did not differ from the 4
subjects who dropped out with respect to age, sex, weight,
height, BMI, vitamin D intake, calcium intake, or baseline
serum 25(OH)D, PTH, serum albumin-adjusted serum calcium,
or total cholesterol concentrations (P . 0.16).
There was good adherence with the egg-consumption pro-
tocols on the basis of the egg-diary entries [median (IQR) com-
pliance was 98.2% (93.7–100%)], and compliance was similar in
the treatment groups (P = 0.6).
Data on egg compliance and measured vitamin D and 25(OH)D
contents of RCT eggs as well as habitual vitamin D intake data
from the FFQ were used to estimate daily total vitamin D intakes
throughout the study period. With the use of a factor of 5, mean6
SD total vitamin D intakes were 9.5 6 3.5, 10.4 6 4.0, and
6.6 6 3.9 mg/d in the vitamin D3–egg, 25(OH)D3-egg, and
control groups, respectively.
There was no difference in mean serum total cholesterol or
body weight at baseline (P . 0.4), and there was no significant
change in weight (P = 0.39) or serum total cholesterol (P = 0.46)
from preintervention to postintervention in the 3 treatment
groups (Table 1).
FIGURE 1 Flow of subjects through the study. 25-D3, 25-hydroxyvitamin D3.
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Effects of vitamin D–egg treatment on serum 25(OH)D and
PTH at the baseline and endpoint are shown in Table 1. Al-
though the preintervention serum 25(OH)D concentration of
the control group was lower than that of the other 2 groups, it
was not significantly so (Table 1). A repeated-measures
ANOVA showed a significant treatment 3 time effect (P =
0.0001). The within-group analysis showed that, although the
control group had a significant decrease in serum 25(OH)D
over the 8-wk winter intervention period (mean 6 SD: 6.4 6
6.7 nmol/L; P = 0.001), there was no significant change in
serum 25(OH)D over the same 8-wk period in the vitamin
D3–egg and 25(OH)D3-egg groups (P . 0.1 for both). The
ANCOVA also showed there was a significant (P = 0.001)
effect of treatment on postintervention serum 25(OH)D con-
centrations whereby, with adjustment for preintervention se-
rum 25(OH)D concentrations, the vitamin D3–egg group and
25(OH)D3-egg group had significantly higher (P # 0.005)
postintervention serum 25(OH)D concentrations compared
with those in the control group. There was no significant (P .
0.3) difference in postintervention serum 25(OH)D concen-
trations between the vitamin D3–egg and 25(OH)D3-egg
groups (Table 1).
The percentage (n/total group n) of subjects in each of the 3
groups who had postintervention serum 25(OH)D concentra-
tions ,25 nmol/L [which is the European Union threshold of
vitamin D deficiency (44)] was 22.2% (4/18), 0% (0/16), and 0%
(0/17) for the control, vitamin D3–egg, and 25(OH)D3-egg
groups, respectively (P = 0.019). The percentage (n) of subjects
in each of the 3 groups who had postintervention serum 25(OH)D
concentrations ,30 nmol/L [which is the US threshold of
vitamin D deficiency (3)] was 38.9% (7/18), 18.8% (3/16), and
5.9% (1/17) for the control, vitamin D3–egg, and 25(OH)D3-egg
groups, respectively (P = 0.057).
There was no significant difference in preintervention or post-
intervention serum PTH concentrations in the 3 treatment groups
(Table 1). A repeated-measures ANOVA confirmed a lack of
a significant treatment 3 time effect (P . 0.6). The within-group
analysis showed that although there was a trend toward a significant
increase in serum PTH (P = 0.050) in the control group over the
8-wk winter intervention period, there was no significant change in
serum PTH over the same 8-wk period in the vitamin D3–egg and
25(OH)D3-egg groups (P. 0.7 for both). There was no significant
interaction between treatment and sex in any of the serum 25(OH)D
or PTH statistical analyses (P . 0.18 for both).
TABLE 1
Selected baseline characteristics of subjects who entered the intervention study, weight, and serum total cholesterol, 25
(OH)D, and PTH concentrations in treatment groups at the baseline and endpoint of the 8-wk intervention in apparently
healthy adults1
Treatment group
PControl Vitamin D3 eggs 25(OH)D3 eggs
Baseline, n 19 17 19 —
Sex, M:F, n 9:10 8:9 10:9 0.930
Age, y 55.8 6 7.52 56.2 6 5.5 53.8 6 5.8 0.498
Height, m 1.70 6 0.12 1.70 6 0.09 1.71 6 0.09 0.807
BMI, kg/m2 25.8 6 3.5 26.5 6 5.0 24.4 6 3.7 0.300
Habitual dietary vitamin D, mg/d 6.0 6 4.0 6.7 6 3.5 6.9 6 4.0 0.796
Habitual dietary calcium, mg/d 842 (670, 1014)3 961 (764, 1739) 762 (666, 1257) 0.115
Endpoint, n 18 16 17 —
Weight,4 kg
Preintervention 75.1 6 12.7 78.3 6 20.1 73.4 6 16.1 0.654
Postintervention 72.8 6 15.6 78.2 6 19.9 72.3 6 15.6 0.387
Serum total cholesterol,4 mmol/L
Preintervention 5.2 6 0.8 5.3 6 0.9 5.5 6 0.8 0.435
Postintervention 5.0 6 0.8 5.2 6 0.9 5.4 6 0.6 0.463
Serum 25(OH)D,4 nmol/L
Preintervention 41.2 6 14.1 48.2 6 18.9 49.4 6 15.8 0.102
Postintervention 34.8 6 11.4a,* 50.4 6 21.4b 49.2 6 16.5b ,0.0001
Serum PTH,4 ng/mL
Preintervention 41.5 (35.0, 62.3) 48.9 (40.4, 53.9) 43.0 (39.6, 59.5) 0.991
Postintervention 47.0 (39.0, 68.4) 47.7 (36.8, 58.5) 44.9 (37.4, 58.6) 0.606
1All preintervention (baseline) blood samples were taken between 5 and 30 January 2015. All postintervention
(endpoint) blood samples were taken between 3 and 30 March 2015. P values for baseline comparisons by intervention
group were determined with the use of a 1-factor ANOVA. P values for endpoint comparisons by intervention group were
determined with the use of an ANCOVA (with adjustment for the baseline variable being tested) followed by Tukey’s test.
Different superscript letters represent significant (P # 0.005) differences in group means. *Value was significantly different
from the baseline value within the group, P = 0.001 (paired t test). PTH, parathyroid hormone; 25(OH)D, 25-hydroxyvi-
tamin D; 25(OH)D3, supplemental 25-hydroxyvitamin D3.
2Mean 6 SD (all such values).
3Median; IQR in parentheses (all such values for nonnormally distributed variables).
4Repeated-measures ANOVA was used to test the treatment 3 time interaction, and the same trend was observed for
weight (P = 0.38), serum total cholesterol (P = 0.86), serum 25(OH)D (P = 0.0001), and PTH (P = 0.6). There was no
significant (P . 0.2 in all cases) interaction with sex.
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An intention-to-treat analysis of postintervention serum
25(OH)D (with the use of inputted values for the 4 subjects who
dropped out during the study) showed similar findings (P #
0.0001) with a significant decrease in the control group (P #
0.002) but no significant difference in either of the 2 vitamin
D–enhanced–egg treatment groups (P . 0.17) (data not
shown).
DISCUSSION
Summary of main findings
Despite numerous vitamin D and 25(OH)D3 hen-feeding
studies over the past 15 y, which collectively have clearly
shown the viability of increasing the vitamin D or 25(OH)D
content of eggs (10–16), the current study, to our knowledge, is
the first to investigate the effect of such vitamin D–enhanced
eggs on vitamin D status in humans. The current RCT showed
that the consumption of 7 vitamin D– or 25(OH)D3-enhanced
eggs/wk, both of which were shown to possess consumer ac-
ceptability and had no effect on weight or serum total cho-
lesterol, maintained serum 25(OH)D concentrations in healthy
adults and protected against its decline during the 8 wk of
winter. Such a decline in serum 25(OH)D concentrations be-
tween January and March was evident in the control group,
who consumed #2 commercially available eggs/wk. This de-
cline in serum 25(OH)D is in line with that reported in the
placebo groups in our previous RCTs of adults over a similar
time frame during the winter (19, 45). Also note that the
vitamin D–enhanced eggs, which exhibited these vitamin
D–status protective effects, were achieved by the addition of
either vitamin D3 (3000-IU/kg diet) or 25(OH)D3 (0.075-mg/kg
diet) to the hens’ feeds at amounts that are allowable by European
Council directives (17, 18), whereas the majority of previous
studies used amounts that exceeded these maximum allowable
contents (10–12, 14, 15).
The consumption of the enhanced eggs as part of the par-
ticipants’ usual diets led to a mean daily intake (MDI) ofw10 mg
vitamin D/d, which, in turn, resulted in postintervention mean
serum 25(OH)D concentrations .40 nmol/L. These results are
consistent with the Institute of Medicine’s estimated average
requirement of 10 mg/d (3) even at a time of the year during
which the vitamin D status would be expected to decline to
a nadir (33). The vitamin D MDI ofw10 mg/d in both vitamin
D–enhanced–egg groups was also sufficient to prevent, or
dramatically diminish, the prevalence of vitamin D deficiency
depending on the selection of serum 25(OH)D threshold to
define deficiency. For example, none of the participants in either
of the 2 vitamin D–enhanced–egg groups had postintervention
serum 25(OH)D concentrations ,25 nmol/L [i.e., the United
Kingdom and European Union definition of vitamin D deficiency
(44, 46)], whereas 6–19% of participants had postintervention
serum 25(OH)D concentrations,30 nmol/L [the US definition of
vitamin D deficiency (3)]. In contrast, the prevalences of serum
25(OH)D concentrations ,25 and ,30 nmol/L were 22% and
39%, respectively, in the control group. However, because
baseline serum 25(OH)D concentrations were lower, even if not
significantly so, in this group than in the 2 vitamin D–enhanced–
egg groups, it may have led to the slightly higher endpoint
prevalence of vitamin D deficiency compared with that in the
placebo groups in our previous vitamin D RCTs [w33%, on
average, with serum 25(OH)D concentrations ,30 nmol/L (29,
30, 45)]. The increase in serum PTH in the control group failed
to reach significance, which may have been related to the mag-
nitude of the drop in serum 25(OH)D (6.4 nmol/L). There was
no change in serum PTH in the 2 vitamin D–enhanced–egg
groups, which might have been expected because of the lack of
a change in serum 25(OH)D over the 8 wk.
Consumer acceptability of vitamin D–enhanced eggs
It was also important that the 25(OH)D3- or vitamin D3–derived
eggs had equal consumer acceptability profiles on the basis of
the current sensory evaluation because any alteration to a sen-
sory perception of a food that may be deemed negative by the
consumer will affect their decision to consume the product. Two
previous studies have shown that eggs produced from hens that
were given additional vitamin D3 in their feeds had similar
sensory profiles as control eggs (11, 14), but the studies tested
amounts of addition well above the European allowable upper
amount, and neither study included eggs from hens that were fed
25(OH)D3.
Role of 25(OH)D in the vitamin D–enhanced eggs
The current study did not set out specifically to answer the
question of whether the relative potency of 25(OH)D to vitamin
D3 is 5 or some other factor as has been assessed in previous
human and pig studies (19–21, 39, 47); instead, we wished to
test the impact of vitamin D–enhanced eggs on human vitamin
D status. In our study, it was assumed that 25(OH)D has
a higher effectiveness in terms of raising serum 25(OH)D than
vitamin D3 does. For example, the calculation of total vitamin
D activity of the eggs applied a conversion factor of 5 for
25(OH)D, as reported by us previously (19), and this factor has
been used in several food-composition tables (25–27). The
use of these total vitamin D–activity estimates meant that the
vitamin D3–egg and 25(OH)D3-egg groups received an ad-
ditional 3.5 and 4.5 mg vitamin D/d, respectively, which,
together with the habitual dietary vitamin D, yielded an MDI
w10 mg/d. Of note, the current USDA National Nutrient
Database for Standard Reference suggests that the vitamin D
content of 100 g raw egg is 2 mg (48), an estimate that does
not include 25(OH)D. Accordingly, estimates of vitamin D
intake from the NHANES in the United States did not ac-
count for the contribution of 25(OH)D (4). Taylor et al. (49)
recently performed some modeling to include food-derived
25(OH)D in intake estimates for US adults, the effect of
which would be even more pronounced should vitamin
D–enhanced eggs become more widespread in the United
States. For example, the total vitamin D content of the eggs
used in the analysis by Taylor et al. (49) at 5.7 mg/100 g
whole egg, and which was very similar to that in the com-
mercial eggs and vitamin D3–enhanced eggs that were used
in this study (5.7 and 6.0 mg/100 g whole egg, respectively),
could be increased to 7.7 mg/100 g whole egg if 25(OH)D3
eggs were used. In the United States, the Food and Drug
Administration designated 25(OH)D as having a generally
recognized as safe status for inclusion in chicken feeds
(0.069-mg/kg diet) (50).
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Strengths and limitations
This RCT of the impact of vitamin D–enriched eggs on vi-
tamin D status in adults, which is the first such study to our
knowledge, was underpinned by hen-feeding studies to specifi-
cally produce vitamin D3– or 25(OH)D3-enhanced eggs and also
by sensory trials to ensure the consumer acceptability of the
eggs. The purposeful selection of habitual low consumers of
eggs (#2 eggs/wk) in the control group for the pragmatic rea-
sons of feasibility and to enhance compliance to limited egg
consumption may have led to some degree of allocation bias.
The selection may have contributed to the lower baseline serum
25(OH)D than that in the vitamin D–enhanced–egg groups, al-
though it was not significantly so. In turn, the lower baseline
25(OH)D might have contributed to a lower postintervention
serum 25(OH)D in the control group and could explain the
measured difference of 14.4–15.6 nmol/L between control and
vitamin D–enhanced–egg groups compared with the more-predicted
12-nmol/L difference. However, the statistical analysis took
baseline serum 25(OH)D concentrations into account, and
moreover, the repeated-measures ANOVA and post hoc tests
showed that there was no change in serum 25(OH)D concen-
trations from preintervention to postintervention in either vi-
tamin D–enhanced–egg group despite a significant decrease in
the control group. The current study did not include a wider
dietary assessment tool and, thus, did not assess the effect of
the consumption of 7 vitamin D–enhanced eggs/wk on fat or
energy intake; however, body weight and serum cholesterol
were unaffected over the 8 wk of the RCT. Finally, although
the inclusion of vitamin D3 or 25(OH)D3 in hen feeds led to the
production of vitamin D–enhanced eggs with vitamin D–status
protective effects in the current study, it should be stressed that
the hens would have received commercial diets that contained
vitamin D3 before the commencement of the experimental di-
ets. Therefore, it is possible that hens that are placed on diet
with 25(OH)D3 only (and no vitamin D3) from a very-early age
may produce eggs with an altered total vitamin D activity.
In conclusion, the weekly consumption of 7 vitamin D–
enhanced eggs, which are produced by hens that are provided
with feed containing vitamin D [either as vitamin D3 or
25(OH)D3] at the allowable maximum content has an impor-
tant impact on winter vitamin D status in adults.
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